Clinical Trials Directory

Trials / Conditions / Staphylococcal Infection

Staphylococcal Infection

13 registered clinical trials studyying Staphylococcal Infection.

StatusTrialSponsorPhase
WithdrawnEffectiveness of Intravenous Immunoglobulins (IVIG) in Toxic Shock Syndromes in Children
NCT02899702
Hospices Civils de LyonPhase 4
CompletedStudy to Assess Eradication of Nasal Carriage of Staphylococcus Aureus (SA) With Mupirocin (Bactroban 2% Nasal
NCT02284555
Destiny Pharma PlcPhase 4
CompletedSafety and Efficacy of Mupirocin in Eradicating Colonization With S. Aureus in Critically Ill Infants
NCT01827358
National Institute of Allergy and Infectious Diseases (NIAID)Phase 2
CompletedStudy of the Safety and Local Tolerability of Intranasal Gel Formulations of XF-73
NCT01592214
National Institute of Allergy and Infectious Diseases (NIAID)Phase 1
CompletedStaphylokinase and ABO Group Phenotype: New Players in Staphylococcus Aureus Implant-associated Infections Dev
NCT02812446
Nantes University Hospital—
CompletedUncomplicated Skin and Soft Tissue Infections Caused by Community-Associated Methicillin-Resistant Staphylococ
NCT00730028
National Institute of Allergy and Infectious Diseases (NIAID)Phase 2
CompletedStrategies Using Off-Patent Antibiotics for Methicillin Resistant S. Aureus "STOP MRSA"
NCT00729937
National Institute of Allergy and Infectious Diseases (NIAID)Phase 2 / Phase 3
CompletedEfficacy Study of Rapid Test to Prevent Hospital Transmission of Methicillin-Resistant Staphylococcus Aureus (
NCT00846105
Erasme University HospitalN/A
CompletedA Study of MK-3009 in Japanese Patients With Skin or Blood Stream Infections Caused by Methicillin-resistant S
NCT00770341
Merck Sharp & Dohme LLCPhase 3
CompletedMicroPhage S. Aureus / MSSA / MRSA Blood Culture Beta Trial
NCT00814151
MicroPhage, Inc.—
CompletedV710 Clinical Study in Healthy Male Japanese Subjects (V710-006) (COMPLETED)
NCT00735839
Merck Sharp & Dohme LLCPhase 1
CompletedComparison of Cephalexin Versus Clindamycin for Suspected CA-MRSA Skin Infections
NCT00352612
Aaron ChenPhase 4
CompletedThe Utility of Levofloxacin-Rifampin in the Therapy of Prosthetic Joint Infection
NCT00279864
Mayo Clinic—